Cargando…

ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis

The upregulation of ELTD1 ([epidermal growth factor (EGF), latrophilin and seven transmembrane domain-containing 1] on chromosome 1) in tumor cells has been reported in several types of cancer and correlates with poor cancer prognosis. However, the role of ELTD1 in glioma progression remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junjun, Shen, Jianying, Wang, Zhen, Xu, Hao, Wang, Qiangping, Chai, Songshan, Fu, Peng, Huang, Tao, Anas, Omarkhalil, Zhao, Hongyang, Li, Jinsong, Xiong, Nanxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761139/ https://www.ncbi.nlm.nih.gov/pubmed/31554859 http://dx.doi.org/10.1038/s41598-019-50375-x

Ejemplares similares

Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF‐κB signaling
por: Li, Junjun, et al.
Publicado: (2019)

CXCL8 Promotes Glioma Progression By Activating The JAK/STAT1/HIF-1α/Snail Signaling Axis
por: Chen, Zhiming, et al.
Publicado: (2019)

14‐3‐3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling
por: Li, Junjun, et al.
Publicado: (2019)

Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2020)

ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
por: Zalles, Michelle, et al.
Publicado: (2021)

CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction]
Publicado: (2023)

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma
por: Huang, Hua, et al.
Publicado: (2021)

Remodelling and Treatment of the Blood-Brain Barrier in Glioma
por: Wang, Yihao, et al.
Publicado: (2021)

ELTD1—An Emerging Silent Actor in Cancer Drama Play
por: Sevastre, Ani-Simona, et al.
Publicado: (2021)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent
por: Kan, Anna, et al.
Publicado: (2018)

ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype
por: Sheldon, Helen, et al.
Publicado: (2021)

RNF7 promotes glioma growth via the PI3K/AKT signalling axis
por: Tang, Nan, et al.
Publicado: (2022)

ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer
por: Sun, Jiawei, et al.
Publicado: (2021)

LncRNA MALAT1/miR‐129 axis promotes glioma tumorigenesis by targeting SOX2
por: Xiong, Zhiyong, et al.
Publicado: (2018)

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015)

Accuracy of magnetic resonance imaging texture analysis in differentiating low-grade from high-grade gliomas: systematic review and meta-analysis
por: Wang, Qiangping, et al.
Publicado: (2019)

FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathway
por: Zeng, Yibin, et al.
Publicado: (2023)

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
por: Niinivirta, Marjut, et al.
Publicado: (2020)

Runx1 promotes the development of glioma cells by regulating JAK-STAT signalling pathway
por: Zhang, Yong, et al.
Publicado: (2019)

HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling
por: Xue, Xiang, et al.
Publicado: (2016)

REST Targets JAK–STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells
por: Huang, Tan, et al.
Publicado: (2023)

Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway
por: Li, Bei, et al.
Publicado: (2021)

Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model
por: Zalles, Michelle, et al.
Publicado: (2019)

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
por: Zalles, Michelle, et al.
Publicado: (2020)

Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion
por: Guihurt Santiago, Jonathan, et al.
Publicado: (2021)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Ruxolitinib induces apoptosis of human colorectal cancer cells by downregulating the JAK1/2-STAT1-Mcl-1 axis
por: Li, Xia, et al.
Publicado: (2021)

A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007
por: Zalles, Michelle, et al.
Publicado: (2021)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile
por: Favara, David M., et al.
Publicado: (2019)

Hybrid surgery for coexistence of cerebral arteriovenous malformation and primitive trigeminal artery: A case report and literature review
por: Wang, Lesheng, et al.
Publicado: (2022)

Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis
por: Wei, Jianwei, et al.
Publicado: (2021)

Computational models of the JAK1/2-STAT1 signaling
por: Gambin, Anna, et al.
Publicado: (2013)

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
por: Masiero, Massimo, et al.
Publicado: (2013)

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway
por: Wang, Weiguo, et al.
Publicado: (2019)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
por: Shi, Lewis Zhichang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b7t95v019drn8sctk8b6b57h38